Early signs of supply tightening are beginning to emerge across global medicine supply chains, despite no significant increase in official shortage notifications. In practice, disruption appears first in supplier behaviour, lead times, and freight complexity—well before it is reflected in formal data.

Dear Healthcare Professional,   Shortage of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999)   Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) in Australia.   The Australian registered medicine, DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R:...

Sandip Manku, Managing Director and Pharmacist at Pro Pharmaceuticals Group, attended Medicines Management 2025 (MM2025) on Friday 28 November. It was an excellent opportunity to meet with our hospital customers, reconnect with colleagues across the pharmacy sector, and discuss the real-world pressures that medicine shortages continue to place on clinicians and patients nationwide. One session that strongly aligned with our work highlighted several key themes: Most hospitals still do not...